MARKET

ITCI

Intra-Cellular Therapies
ITCI
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-37.7116
20.58
12.20
14,047,000,227.12
Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews
Benzinga · 04/02/2025 22:01
*News On Intra-Cellular Therapies Inc. (ITCI) Now Under JNJ
Dow Jones · 04/02/2025 21:08
Intra-Cellular Therapies Completes Merger with Johnson & Johnson
TipRanks · 04/02/2025 20:30
Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended
Benzinga · 04/02/2025 16:26
Intra-Cellular Therapies Price Target Maintained With a $132.00/Share by Cantor Fitzgerald
Dow Jones · 04/02/2025 14:42
Cantor Fitzgerald Reiterates Neutral on Intra-Cellular Therapies, Maintains $132 Price Target
Benzinga · 04/02/2025 14:32
Intra-Cellular Therapies (ITCI) Receives a Rating Update from a Top Analyst
TipRanks · 04/02/2025 12:56
Johnson & Johnson Set To Complete Acquisition Of Intra-Cellular Therapies By April 2, 2025
NASDAQ · 04/02/2025 02:33
More

Webull offers Intra-Cellular Therapies stock information, including NASDAQ: ITCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ITCI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ITCI stock methods without spending real money on the virtual paper trading platform.